Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-005544

Chief Executive Officer sold 9,879 shares at $5.67 ($56,009)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2021-01-19 Sale −9,879 $5.67 $56,009 13,529 D
Open-market sales · 9,879 sh · avg $5.67 · $56,009
Loading xslF345X03/tm213569-1_4seq1.xml…